dual CDK4/6 inhibitors Genentech/Paraza Pharma/WuXi AppTec

N/A

Report date: 2025/03/19 09:01:39
NME

Base Information

Drug Namedual CDK4/6 inhibitors Genentech/Paraza Pharma/WuXi AppTec
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 6Cyclin-dependent kinase 4
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesParaza Pharma IncWuxi Apptec (Tianjin) Co LtdGenentech Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A